Sign inJoin waitlistJoin the waitlist

Gottfried E. Konecny

Lead Clinician for Gynecologic Oncology in the Department of Medicine · UCLA

Credentials: · ·

History

Medicine · UCLA
Present

Mayo Clinic College of Medicine and Science
Until 2007
Klinikum Grosshadern
Until 1996
Ludwig-Maximilians Universitat Muenchen
1991
Klinikum Grosshadern
Until 1991

Research

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
Journal of Clinical Oncology · 2012 · 2,127 citations
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2017 · 1,408 citations
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
The Lancet Oncology · 2017 · 969 citations

Dennis Slamon
39 papers
Boris Winterhoff
34 papers · 20 as a resident
Beth Karlan
19 papers
Andrew Berchuck
17 papers · 6 as a resident
Mark Pegram
14 papers
David O'Malley
11 papers
Kathleen Moore
10 papers
Elizabeth Swisher
9 papers
LH
Lynn Hartmann
9 papers
Premal Thaker
9 papers
Andrea Hendrickson
8 papers · 2 as a fellow
Gary Keeney
8 papers

Clinical trials

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Principal investigator · Recruiting · Phase 2
Jonsson Comprehensive Cancer Center
2020–2028
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
Principal investigator · Active not recruiting · Phase 2
Jonsson Comprehensive Cancer Center
2019–2025
A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2011–2020
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
Study chair · Terminated · Phase 2
Translational Research in Oncology
2009–2014